Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease | Zendy

Michael D. Dake | Zendy; Gary M. Ansel | Zendy; Michael R. Jaff | Zendy; Takao Ohki | Zendy; Richard R. Saxon | Zendy; H. Bob Smouse | Zendy; Thomas Zeller | Zendy; Gary S. Roubin | Zendy; Mark W. Burket | Zendy; Yazan Khatib | Zendy; S.A. Snyder | Zendy; Anthony Ragheb | Zendy; Jennifer White | Zendy; Lindsay Machan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease

Author(s) -

Michael D. Dake,

Gary M. Ansel,

Michael R. Jaff,

Takao Ohki,

Richard R. Saxon,

H. Bob Smouse,

Thomas Zeller,

Gary S. Roubin,

Mark W. Burket,

Yazan Khatib,

S.A. Snyder,

Anthony Ragheb,

Jennifer White,

Lindsay Machan

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.111.962324

Subject(s) - medicine , stent , angioplasty , surgery , target lesion , restenosis , balloon , percutaneous , lesion , drug eluting stent , bare metal stent , popliteal artery , paclitaxel , radiology , percutaneous coronary intervention , chemotherapy , myocardial infarction

Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study was designed to compare the 12-month safety and effectiveness of a polymer-free, paclitaxel-coated nitinol drug-eluting stent (DES) with percutaneous transluminal angioplasty (PTA) and provisional bare metal stent (BMS) placement in patients with femoropopliteal peripheral artery disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research